• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Innovative Thena Attracts Investment from Binance Labs with Unique Model

user avatar

by Giorgi Kostiuk

a year ago


Binance Labs, the venture capital arm of Binance, has announced its latest investment in Thena, a decentralized exchange (DEX) and liquidity protocol operating on the BNB Chain.

What is Thena

Launched in January 2023, Thena quickly gained traction among users, thanks to its unique ve(3,3) tokenomics model. The platform offers a comprehensive suite of products, including the spot DEX THENA, the perpetual DEX ALPHA, the gamified social trading platform ARENA, and the upcoming launchpad WARP.

Why Binance Labs Chose Thena

The decision to invest in Thena stems from its innovative approach to liquidity management and user-centric design. Alex Odagiu, Investment Director at Binance Labs, described Thena as a key player in the next wave of DeFi growth. Its model allows it to meet various liquidity needs, including stablecoins and tokenized assets.

The ve(3,3) Tokenomics

At the heart of Thena’s success is its ve(3,3) tokenomics model, which incentivizes long-term participation and liquidity provision. Users can lock their $THE tokens for up to two years to receive veTHE for voting and access to platform revenue. veTHE can be traded on secondary markets, ensuring flexibility and engagement.

Thena aims to become a decentralized alternative to centralized exchanges, offering a range of features to make DeFi accessible for both beginners and experienced users.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.